Treatment of collagen-induced arthritis with recombinant plasminogen-related protein B: A novel inhibitor of angiogenesis

Journal of Orthopaedic Science

Volumn 16, Issue 4, 2011, Pages 443-450

  Tanaka, Koichiro ^a   Morii, Takeshi ^b   Weissbach, Lawrence ^c   Horiuchi, Keisuke ^a   Takeuchi, Katsuhito ^a   Toyama, Yoshiaki ^a   Morioka, Hideo ^a  

^a KEIO UNIVERSITY   (Japan)

^b KYORIN UNIVERSITY   (Japan)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS INHIBITOR; BASIC FIBROBLAST GROWTH FACTOR; INTERLEUKIN 1BETA; RECOMBINANT PLASMINOGEN RELATED PROTEIN B; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIANGIOGENIC ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BONE DESTRUCTION; CELL PROLIFERATION; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE SEVERITY; DOWN REGULATION; DRUG MECHANISM; GROWTH INHIBITION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PROTEIN SYNTHESIS REGULATION; RHEUMATOID ARTHRITIS; SYNOVIOCYTE;

EID: 80052507868     PISSN: 09492658     EISSN: 14362023     Source Type: Journal    
DOI: 10.1007/s00776-011-0091-x     Document Type: Article

References (23)

1. L Weissbach BV Treadwell 1992 A plasminogen-related gene is expressed in cancer cells Biochem Biophys Res Commun 186 1108 1114 1379800 10.1016/0006-291X(92)90861-E 1:CAS:528:DyaK3sXkt1Gmtbw%3D
2. H Morioka L Weissbach T Vogel GP Nielsen GT Faircloth L Shao FJ Hornicek 2003 Antiangiogenesis treatment combined with chemotherapy produces chondrosarcoma necrosis Clin Cancer Res 9 1211 1217 12631627 1:CAS:528:DC%2BD3sXhvFKiurw%3D (Pubitemid 36323731)
3. VO Lewis MS O'Reilly M Gehrmann M Llinas J Schaller L Weissbach 2001 Inhibition of tumor growth by plasminogen-related protein-B Anticancer Res 21 2287 2291 11724284 1:CAS:528:DC%2BD3MXovVOqsb0%3D (Pubitemid 33054387)
4. H Morioka T Morii T Vogel FJ Hornicek L Weissbach 2003 Interaction of plasminogen-related protein B with endothelial and smooth muscle cells in vitro Exp Cell Res 287 166 177 12799192 10.1016/S0014-4827(03)00137-X 1:CAS:528:DC%2BD3sXksVyrur0%3D (Pubitemid 36683211)
5. T Tateno A Ichinose 1999 Expression of plasminogen-related gene B varies among normal tissues and increases in cancer tissues FEBS Lett 445 31 35 10069369 10.1016/S0014-5793(99)00093-9 1:CAS:528:DyaK1MXht1OhurY%3D (Pubitemid 29101530)
6. H Sone M Sakauchi A Takahashi H Suzuki N Inoue K Iida H Shimano H Toyoshima Y Kawakami Y Okuda K Matsuo N Yamada 2001 Elevated levels of vascular endothelial growth factor in the sera of patients with rheumatoid arthritis correlation with disease activity Life Sci 69 1861 1869 11693266 10.1016/S0024-3205(01)01264-4 1:CAS:528:DC%2BD3MXmvV2htrs%3D (Pubitemid 32835268)
7. C Salliot M Dougados L Gossec 2009 Risk of serious infections during rituximab, abatacept and anakinra treatments for rheumatoid arthritis: meta-analyses of randomised placebo-controlled trials Ann Rheum Dis 68 25 32 18203761 10.1136/ard.2007.083188 1:STN:280:DC%2BD1M%2FhtlOrsg%3D%3D
8. VO Lewis M Gehrmann L Weissbach JE Hyman A Rielly DG Jones M Llinas J Schaller 1999 Homologous plasminogen N-terminal and plasminogen-related gene A and B peptides: characterization of cDNAs and recombinant fusion proteins Eur J Biochem 259 618 625 10092845 10.1046/j.1432-1327.1999.00055.x 1:CAS:528:DyaK1MXhsFamtbo%3D (Pubitemid 29075487)
9. YL Guo S Wang RW Colman 2001 Kininostatin, an angiogenic inhibitor, inhibits proliferation and induces apoptosis of human endothelial cells Arterioscler Thromb Vasc Biol 21 1427 1433 11557667 10.1161/hq0901.095277 1:CAS:528:DC%2BD3MXntVGkurc%3D (Pubitemid 34219803)
10. MS O'Reilly T Boehm Y Shing N Fukai G Vasios WS Lane E Flynn JR Birkhead BR Olsen J Folkman 1997 Endostatin: an endogenous inhibitor of angiogenesis and tumor growth Cell 88 277 285 9008168 10.1016/S0092-8674(00)81848-6 (Pubitemid 28015876)
11. Rosloniec EF, Cremer M, Kang A, Myers LK. Collagen-induced arthlitis. In: Coligan JE, Kruisbeek AM, Argulies DH, Shevach EM, Strober W, editors. Current protocols in immunology. New York: Wiley; 2001. p. 15.5.1.
12. KM Hildner P Schirmacher I Atreya M Dittmayer B Bartsch PR Galle S Wirtz MF Neurath 2007 Targeting of the transcription factor STAT4 by antisense phosphorothioate oligonucleotides suppresses collagen-induced arthritis J Immunol 178 3427 3436 17339437 1:CAS:528:DC%2BD2sXisVGjsro%3D (Pubitemid 46417607)
13. CQ Chu M Field S Allard E Abney M Feldmann RN Maini 1992 Detection of cytokines at the cartilage/pannus junction in patients with rheumatoid arthritis: implications for the role of cytokines in cartilage destruction and repair Br J Rheumatol 31 653 661 1393370 10.1093/rheumatology/31.10.653 1:STN:280:DyaK3s%2Fgs1ymtQ%3D%3D
14. D Kurosaka K Yoshida J Yasuda T Yokoyama I Kingetsu N Yamaguchi K Joh M Matsushima S Saito A Yamada 2003 Inhibition of arthritis by systemic administration of endostatin in passive murine collagen induced arthritis Ann Rheum Dis 62 677 679 12810435 10.1136/ard.62.7.677 1:CAS:528: DC%2BD3sXlvFajtro%3D (Pubitemid 36760570)
15. ST Choi JH Kim JY Seok YB Park SK Lee 2009 Therapeutic effect of anti-vascular endothelial growth factor receptor I antibody in the established collagen-induced arthritis mouse model Clin Rheumatol 28 333 337 19101756 10.1007/s10067-008-1075-x
16. T Morii L Weissbach 2003 Sphingosine 1-phosphate and cell migration: resistance to angiogenesis inhibitors Biochem Biophys Res Commun 310 884 888 14550287 10.1016/j.bbrc.2003.09.089 1:CAS:528:DC%2BD3sXnvVylur4%3D (Pubitemid 37188705)
17. CM Storgard DG Stupack A Jonczyk SL Goodman RI Fox DA Cheresh 1999 Decreased angiogenesis and arthritic disease in rabbits treated with an alphavbeta3 antagonist J Clin Invest 103 47 54 9884333 10.1172/JCI3756 1:CAS:528:DyaK1MXjsl2msQ%3D%3D (Pubitemid 29031162)
18. Wilder RL. Integrin alpha V beta 3 as a target for treatment of rheumatoid arthritis and related rheumatic diseases. Ann Rheum Dis 2002;61(Suppl2):96-9.
19. RK Jain 2002 Tumor angiogenesis and accessibility: role of vascular endothelial growth factor Semin Oncol 29 3 9 12516032 1:CAS:528: DC%2BD3sXlvFSqsA%3D%3D
20. N Ferrara 2002 Role of vascular endothelial growth factor in physiologic and pathologic angiogenesis: therapeutic implications Semin Oncol 29 10 14 12516033 1:CAS:528:DC%2BD3sXlvFSqsQ%3D%3D
21. N Ferrara HP Gerber J LeCouter 2003 The biology of VEGF and its receptors Nat Med 9 669 676 12778165 10.1038/nm0603-669 1:CAS:528:DC%2BD3sXktFOnur4%3D (Pubitemid 36749215)
22. M Nagashima G Asano S Yoshino 2000 Imbalance in production between vascular endothelial growth factor and endostatin in patients with rheumatoid arthritis J Rheumatol 27 2339 2342 11036826 1:CAS:528:DC%2BD3cXnsFCqsrY%3D
23. G Bergers D Hanahan 2008 Modes of resistance to anti-angiogenic therapy Nat Rev Cancer 8 592 603 18650835 10.1038/nrc2442 1:CAS:528:DC%2BD1cXovV2lsrk%3D